108 related articles for article (PubMed ID: 10023012)
1. Prognostic factors in colorectal cancer.
Cerottini JP; Caplin S; Pampallona S; Givel JC
Oncol Rep; 1999; 6(2):409-14. PubMed ID: 10023012
[TBL] [Abstract][Full Text] [Related]
2. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
3. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
5. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer.
Edna TH; Bjerkeset T
Dis Colon Rectum; 1998 Apr; 41(4):451-9. PubMed ID: 9559629
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
7. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
8. Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.
Mander BJ; Carney LJ; Scott HJ; Donaldson DR
Surgeon; 2006 Aug; 4(4):227-30. PubMed ID: 16892840
[TBL] [Abstract][Full Text] [Related]
9. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
10. The influence of age upon the survival after curative operation for colorectal cancer.
Svendsen LB; Sørensen C; Kjersgaard P; Meisner S; Kjaergaard J
Int J Colorectal Dis; 1989; 4(2):123-7. PubMed ID: 2746133
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
[TBL] [Abstract][Full Text] [Related]
15. Age-associated prognosis following curative resection for colorectal cancer.
Demetriades H; Kanellos I; Vasiliadis K; Angelopoulos S; Vergos O; Kanellos D; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s144-6. PubMed ID: 15655602
[TBL] [Abstract][Full Text] [Related]
16. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and survival after potentially curative surgery for colorectal cancer.
Jadallah F; McCall JL; van Rij AM
N Z Med J; 1999 Jul; 112(1091):248-50. PubMed ID: 10448981
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis of surgically treated colorectal neoplasms. Contribution of multivariate analysis].
Huguier M; Rey C; Chastang C; Houry S; Lacaine F
Gastroenterol Clin Biol; 1989 May; 13(5):463-8. PubMed ID: 2753282
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer--a multivariate analysis of prognostic factors.
Wolters U; Stützer H; Keller HW; Schröder U; Pichlmaier H
Eur J Surg Oncol; 1996 Dec; 22(6):592-7. PubMed ID: 9005146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]